Form 4 · Filed May 11, 2026, 08:30 PM UTC
KZR/Kezar Life Sciences, Inc.
COOPER GRAHAM K — director
AI Thesis
A thesis has not been generated for this filing yet — usually available within 60 seconds of EDGAR publication. Refresh shortly.
Research signal, not investment advice. Form 4 AI surfaces SEC filings and applies an analytical layer — it does not predict prices or recommend trades. Past performance does not guarantee future results. See methodology and public track record for how scores are computed.
Transactions
10 rows| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| May 11, 2026 | D | other | 3,742 | — | — | 0 |
| May 11, 2026 | D | other | 889 | — | — | 0 |
| May 11, 2026 | D | other | 3,500 | — | — | 0 |
| May 11, 2026 | D | other | 5,000 | — | — | 0 |
| May 11, 2026 | D | other | 5,000 | — | — | 0 |
| May 11, 2026 | D | other | 889 | — | — | 0 |
| May 11, 2026 | D | other | 889 | — | — | 0 |
| May 11, 2026 | D | other | 2,600 | — | — | 0 |
| May 11, 2026 | D | other | 2,600 | — | — | 0 |
| May 11, 2026 | D | other | 2,600 | — | — | 0 |
Source: SEC EDGAR raw filing ↗ · Accession 0001396943-26-000002